Sanofi India Limited
Sanofi India Limited is a Public Non-govt company company incorporated in 1956 and based in Maharashtra, India. Sanofi India Limited operates in Hina powder, manufacturing (NIC 24239) with authorized capital of ₹23.50 Cr and paid-up capital of ₹23.03 Cr. For 2017-18, the company reported revenue of ₹2491.40 Cr and profit after tax of ₹326.00 Cr. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
SANOFI INDIA LIMITED is the legal entity of Sanofi India.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Sanofi India Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 25 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 24 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +26d | filed |
| MGT-7 | FY2022-23 | 23 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Sanofi India Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 296877912 | Axis Bank Ltd(Bank) | ₹20.37 Cr | 04 Jul 2019 | Satisfied |
| 380007783 | ICICI Bank Ltd(Bank) | ₹10.64 Cr | 27 Jan 2023 | Satisfied |
| 647008167 | ICICI Bank Ltd(Bank) | ₹12.99 Cr | 12 Mar 2022 | Satisfied |
| 409579699 | Axis Bank Ltd(Bank) | ₹2.52 Cr | 04 Jul 2019 | Satisfied |
Charge IDs, lenders & amounts for Sanofi India Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2017-18 | — |
Detailed Financials
1 FYs| Line item | 2017-18 |
|---|---|
| Income statement | |
| Revenue from operations | |
| Other income | |
| Total income | |
| Total expenses | |
| Profit before tax | |
| Profit / (Loss) after tax | |
| Balance sheet | |
| Equity / Net worth | |
| Borrowings | |
| Current liabilities | |
| Total liabilities | |
| Current assets | |
| Cash & equivalents | |
| Total assets | |
| Employees | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹38.36 Cr | +12.9% | +13.3% | +11.6% |
| Profit after Tax | ₹-53.30 L | -8.0% | +15.1% | +5.1% |
| Net Worth | ₹14.04 Cr | +3.6% | -2.8% | +2.0% |
| Employees | 227 | +32.1% | +22.3% | +6.2% |
Audited financials & ratios for Sanofi India Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2017-18 | +13.09% | — | +16.09% | +11.74% | 0.37 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 3,10,07,893 | 79.26% |
| Institutional Investors | 1 | 8,81,670 | 2.25% |
| Public & Others | 42 | 72,32,887 | 18.49% |
Promoter, institutional & public holding for Sanofi India Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
3 peersEvents & timeline
7External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.